News
Medical Device Network on MSN1d
FDA conditionally approves second cohort of Carmat’s artificial heart studyFollowing the initial cohort completion, the company made improvements to the artificial heart and submitted these changes to ...
A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback